What is Sonic Healthcare Ltd ADR?
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally.
SKHHY · Verdict
Moderate reward · moderate risk
SKHHY stands out on volatility and valuation, but watch the growth signal.
Based on 88% data coverage
SKHHY · Verdict
Top decile vs peers
P/E 20.2×
Rev +1.2% CAGR · earnings -29.4%
5% net margin · 7% ROE
Interest covered 5.2×
Model-based scoring. For information only — not financial advice.
Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 8.43B, and a P/E ratio of 21.6x.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.